Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Absorption, Metabolism, Excretion, and the Determination of Absolute Bioavailability of Niraparib in Subjects With Cancer

NCT02476552 is registered in ClinicalTrials.gov with Tesaro, Inc. as lead sponsor.

NCT NCT02476552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02476552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Absorption, Metabolism, Excretion, and the Determination of Absolute Bioavailability of Niraparib in Subjects With Cancer
Lead sponsor
Tesaro, Inc.
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2015
Completion date
January 31, 2018
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer